维普中文期刊产品整合服务
11篇 您的检索式:作者名="Venner PM"
    题名 作者 年代 出处 被引量
1Double-blinded randomized study of high-dose calcitfiol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators显示文摘Beer TM Ryan CW Venner PM 2007J Clin Oncol2007,25,6:1
2Double-blinded randomized study of high-dose calcitriol plus docetaxel com-pared with placebo plus dovetaxel in androgen-independent prostate cancer:a report from the ASCENT I nvestigators显示文摘Beer TM Ryan CW Venner PM 0,,06:1
3Malignant ascites:demographics,therapeutic efficacy and predictors of survival显示文摘Mackey JR Venner PM 0,,02:1
4Malignant ascites: Demographics, Ther-speutic efficacy and predictors of survival 显示文摘Mackey JR Venner PM 1996Can J Oncol1996,6,2:1
5Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer:a report from the ASCENT Investigators显示文摘Beer TM Ryan CW Venner PM 2007J Clin Oncol2007,25,6:1
6Prostate-specific antigen doubling time is associated with survival in men with hormone-refractory prostate cancer显示文摘Semeniuk RC Venner PM North S 2006Urology2006,68,3:1
7Malignant ascites:demographics,thera-peutic efficacy and predictors of survival显示文摘Mackey JR Venner PM 1996Can J Oncol1996,6,2:1
8Influence of longitu- dinal roughness on friction in EHL contact显示文摘Jacod B Venner CH Lugt PM 2004JTrib2004,126,:1
9Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer:a report from the ASCENT Investigators显示文摘Beer TM Ryan CW Venner PM 2007J Clin Oncol2007,25,6:1
10Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain显示文摘Ernst DS Tannock IF Winquist EW Venner PM Reyno L Moore MJ Chi K Ding K Elliott C Parulekar W 2003Journal of Clinical Oncology2003,21,17:1
11Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators显示文摘Beer TM Ryan CW Venner PM 2007J Clin Oncol2007,25,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费